Detected ·

OMass Therapeutics

$310MSeries C

OMass Therapeutics raised an oversubscribed $310M Series C to fund its drug discovery programmes through clinical proof of concept for congenital adrenal hyperplasia and immunological indications.

Website
—
Amount
$310 000 000 USD
Stage
Series C
Event
Funding round
Detected
2026-10-22 16:07:46 UTC
Signal ID
38bad071-5f05-4920-817f-2aec6ebd73bd

As the API returns it

{
  "id": "38bad071-5f05-4920-817f-2aec6ebd73bd",
  "created_at": "2026-10-22T16:07:46.445054Z",
  "company_name": "OMass Therapeutics",
  "company_website_url": null,
  "company_linkedin_url": "https://www.linkedin.com/company/12654474",
  "event_type": "funding",
  "funding_amount": 310000000,
  "funding_currency": "USD",
  "funding_stage": "series_c",
  "message": "*OMass Therapeutics raised an oversubscribed $310M Series C to fund its drug discovery programmes through clinical proof of concept for congenital adrenal hyperplasia and immunological indications.*"
}

Latest rounds

FLEXECHARGE——LinkedIn
Nimesis Technology€550KOtherLinkedIn
Remanence$30MSeedLinkedIn
Noeri$110M—LinkedIn
Nimesis Technology——Site / LinkedIn
Nomadic Drones$6MSeedSite / LinkedIn
ODAIA—Series CLinkedIn
Remanence$30MSeedLinkedIn
Model ML$250MSeries BLinkedIn
Commit Biologics$60MSeedLinkedIn
Treat Health€3MPre-SeedLinkedIn
Tiberius Aerospace$85MSeries ASite / LinkedIn
Numa$45MSeries CLinkedIn
ODAIA—Series CSite / LinkedIn
Pulpex£24.6MSeries DSite / LinkedIn
Q-CTRL$290MSeries CLinkedIn
Arva AI$20MSeries ALinkedIn
Arva AI$20MSeries ASite / LinkedIn
Fairly$22.4MSeries ASite / LinkedIn
Previsia€3.8MSeedSite / LinkedIn
August AI$12M—Site / LinkedIn
MountAIn€7.3M—Site / LinkedIn
Treat Health€3M—Site / LinkedIn
Gotham FC$100MOtherSite / LinkedIn
Isomorphic Labs$5B—Site / LinkedIn
End Close$3.5MSeed—
Model ML$250MSeries BSite / LinkedIn
Remanence$30M——
Remanence$30M——
Hadl.ai——LinkedIn
Remanence€27.2MSeed—
Bricks Performance SystemDKK 1.5M—Site / LinkedIn
Noeri$110M——
Remedy Robotics$62MOtherLinkedIn
COUNT$6.5MSeedSite / LinkedIn
Nimble Science—AngelSite / LinkedIn
Corma$125MSeries A—
Bedrock Energy$24M—LinkedIn
Corma$125MSeries ALinkedIn
ComeHome—OtherSite / LinkedIn
Queens Court Capital——Site / LinkedIn
FLEXECHARGE——Site / LinkedIn
Numa$45MSeries CLinkedIn
The Vaccine Group (TVG)£500KOtherSite / LinkedIn
AgentWeb—Other—
Corma$125MSeries ALinkedIn
Geminus—Other—
Drogue—Pre-SeedSite / LinkedIn
Traitomic€20M—LinkedIn
Centese——Site / LinkedIn